Theriva Biologics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-15.2M | $-27.3M | $-43.7M | $-19.8M | $-12.3M | $-17.1M | $-8.1M | $-1.7M |
| Depreciation & Amortization | $245.0K | $157.0K | $72.0K | $20.0K | $43.0K | — | — | — |
| Depreciation | — | — | — | $20.0K | $43.0K | $63.0K | $144.0K | $346.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $3.4M | $4.0M | $3.2M | $2.5M | $1.7M | $1.9M | $973.0K | $400.0K |
| Net Cash from Operating Activities | $-20.2M | $-27.9M | $-38.9M | $-16.1M | $-7.7M | $-8.9M | $-2.9M | $-1.1M |
| Investing Activities | ||||||||
| Capital Expenditures | $212.0K | $569.0K | $501.0K | $48.0K | $36.0K | $10.0K | $0 | $12.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-212.0K | $-569.0K | $-501.0K | $-48.0K | $-36.0K | $-10.0K | $-75.0K | $65.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $18.5M | $26.7M | $42.7M | $19.0M | $12.4M | $12.2M | $7.0M | $1.0M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-20.4M | $-28.5M | $-39.4M | $-16.1M | $-7.8M | $-8.9M | $-2.9M | $-1.2M |